In summary, our findings demonstrate that the abnormality of the SIRT1/AMPK signaling pathway is involved in the dysfunction of lipid synthesis and degradation during NAFLD development. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.